London's blue chip index reached a new all-time high on Tuesday morning, with the mood in Europe largely optimistic before focus turns stateside. A host of major banks release earnings before the opening bell in New York. In addition, there is a US inflation reading to come. Among London shares, Experian impressed, though trading statements from Barratt Redrow and B&M disappointed. The FTSE...

Stock prices opened mixed in London on Monday, as UK house price growth sped up in May, while investors await a UK manufacturing purchasing managers' index reading. Meanwhile overseas, as Swissquote's Ipek Ozkardeskaya put it: 'Trade tensions are heating up again. Not only does Donald Trump seem unfazed by growing questions around the legitimacy of his tariffs, but he also accused China of...

London stocks closed in the green on Wednesday, boosted by gains in the banking sector, despite investors' disappointment as BP announced a reduced buyback programme.The FTSE 100 index closed up 62.79 points, 0.7%, at 8,731.46. The FTSE 250 ended up 147.62 points, 0.7%, at 20,595.90, while the AIM All-Share closed up 3.44 points, 0.5%, at 711.50.The Cboe UK 100 ended up 0.9% at 874.86, the...

Blue chip stock prices in London, Paris and Frankfurt were comfortably in the green at Wednesday midday, with Lloyds up after it received higher price targets from Deutsche Bank Research and Barclays.In UK news, the defence secretary has suggested the real-terms increase in defence spending year-on-year will be only around half the £13.4 billion figure cited by the prime minister.John Healey...

2024 revenue up 7.7%, profit up 16.4%Mid-term guidance reiteratedDividend up 3%Medical products company Convatec (CTEC) revealed strong organic revenue growth of 7.7% and a double-digit advance in adjusted earnings per share to 15.2 cents for 2024, ahead of consensus forecasts.The results were well received with shares gaining more than 6% to 262.2p, topping the FTSE 100 leaderboard. Over the...

Law Debenture Corporation (LWDB) 899pMarket cap: £1.19 billionFinancial markets have been rocked by the twists and turns of the tariff situation created by US president Donald Trump, which threatens to turn into a full-blown trade war. This has spooked investors since it could result in higher inflation and halt further interest rate cuts, which is likely to be negative for equities and could...

Sales and profit outlook upgradedAll divisions contributingStrategic plans paying offGlobal medical products company Convatec (CTEC) jumped 20% to top the FTSE 100 leaderboard after upgrading full year sales growth and margin guidance in an unscheduled trading update.It is one of the biggest one-day advances in the shares since the business listed on the stock market in 2016 and means they are...

Stock prices in blue chip indices in London, Paris and Frankfurt were in the red on Tuesday morning, as traders digest an increasing likelihood that incoming US president Donald Trump will enact punitive tariffs and a very hawkish stance on China.'The latest moves from Trump's camp, especially with China hawks joining his inner circle, are sending chills through the markets and casting a...

Organic revenue up 6.5% in Q1Advanced wound care outlook cutFull-year outlook maintainedShares in Convatec (CTEC) fell 4% to 255.7p after the medical products maker flagged short-term uncertainty in Advanced Wound Care leading to a softer outlook for the division.The news took the shine off a strong start to the year with first-quarter organic revenue up 6.5% which was slightly ahead of market...

Full year sales and profit beat estimatesMedium term guidance raisedImproved commercial executionShares in medical products company Convatec (CTEC) traded 7% higher to 270p after full year sales and profit came in ahead of market expectations and management raised guidance.The shares registered new 12-month and five-year highs which means they have doubled over the last five years compared...

Organic sales growth acceleratesFull-year growth targets increasedNo impact seen from obesity drugsMedical products company Convatec (CTEC) continues to generate strong organic sales growth, prompting management to increase its full-year sales and earnings guidance for a second time.The shares responded positively, gaining 3% to 214.8p leaving them down around 8% year-to-date. Sales for...

Snap up medical products outfit ConvaTec (CTEC) as a multi-year turnaround gains traction. Recent evidence for this came as the company raised full year guidance for the second time this year (2 August), delivering accelerated revenue growth in the six-month period to 30 June.After a downward trend in the share price, the positive news has helped to turn the tide and we think this could be the...

Stocks in Europe were rocked by Fitch lowering its US rating on Wednesday, evoking memories of S&P doing the same almost 12 years ago to the day.Stocks suffered then, and they similarly struggled now. Barely a handful of London's 100-strong flagship large-cap benchmark were on the up, with BAE Systems among those shielded by the fallout after it boosted guidance.'There is a saying that when...

Full year organic sales growth guidance raised to a new range of 6% to 7.5%Adjusted operating profit margin guidance increased to 20.5%Medium term operating margin target in mid-20% rangeThe multi-year turnaround at medical products company Convatec (CTEC) finally seems to be gaining traction after the company raised full year guidance for the second time this year and delivered accelerated...

Good start to 2023 against tough prior year comparisonFull year organic sales guidance increasedOn track with new product launchesMedical products group ConvaTec (CTEC) said it has made a good start to the year after registering organic sales growth of 3.1% in the first four months to 30 April, against a tough prior year comparative.The company said improving momentum and confidence in the...

Convatec head sells shares to meet tax liabilitiesFerro-Alloy Resources chief buys over £600,000 sharesMorgan Advanced Materials director snaps up 35,000 sharesConvatec Group (CTEC) chief executive Karim Bitar has sold 429,441 shares at 216p for £929,479 on 2 May to meet income tax and social security liabilities.The medical products and technologies company based in Reading sells various...

- Index changes to be announced tonight- Three new names to join the FTSE 100- Four new faces in the mid-cap FTSE 250Investors with FTSE tracker funds will be keenly waiting for details of the latest index reshuffle due to be published after the market close tonight.As well as changes to the FTSE 100 big-cap index there are expected to be several changes to the FTSE 250 mid-cap benchmark and...

- Treatt chairman buys stock after profit warning- The company's CEO also buys shares- ConvaTec non-exec buys after better-than-expected resultsTwo directors bought shares in flavour and fragrance ingredients maker Treatt (TET) on 15 August in the wake of a profits warning which sent shares sliding by over 30%.Chairman Tim Jones purchased 8,944 shares across, taking his total interest to...

- First half earnings beat estimates- Convatec confirms full year guidance- Advanced wound care and infusion care the strongest divisionsInvestors welcomed the latest trading update from medical solutions firm Convatec (CTEC), lifting the shares 7.3% to a new 12-month high of 247p.While the headlines weren't market-moving, the fact the company confirmed its full year guidance raised hopes it...

Global medical solutions group Convatec (CTEC) said it has made a good start to the 2022 financial year with organic revenues up 6% year-on-year.Despite raising guidance on cost inflation to between 8% and 9% compared with 5% previously, the company reiterated full-year guidance.That is, organic revenues are anticipated to grow between 4% and 5% with an operating margin of at least...